Cell and Gene Therapy may be a potential weapon in the therapeutic armamentarium for the novel coronavirus disease (COVID-19). Join our upcoming webinar to learn about the application of Cell and Gene Therapy (CAGT) to COVID-19. We will share real-time clinical insights on the pandemic and the COVID-19 CAGT clinical trial landscape mined from IQVIA data. We will explore how CAGT is being applied to treat the disease and discuss key study design and operational considerations for new CAGT trials. Finally, we will review the impact of COVID-19 on the CAGT clinical trial environment and share lessons learned conducting CAGT trials during the early period of the COVID-19 pandemic that may help plan for the future.

Key take-aways:

• Gain real-time insights into the current clinical landscape for COVID-19
• Learn how CAGT therapies are being applied to treat of COVID-19
• Review key study design and operational considerations for COVID-19 CAGT trials
• Review best practices for managing ongoing CAGT trials in the environment of COVID-19 and discuss strategies to risk mitigate for the future